Lyla J. Stanland

Also affiliated with Tenax Therapeutics (United States)

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “CBF-Beta Mitigates PI3K-Alpha–Specific Inhibitor Killing through PIM1 in PIK3CA -Mutant Gastric Cancer”.

CBF-Beta Mitigates PI3K-Alpha–Specific Inhibitor Killing through PIM1 in PIK3CA -Mutant Gastric Cancer

Molecular Cancer Research(2023)10.1158/1541-7786.mcr-23-0034

N/A

0DataRank · unranked

13 citations

Hazel X. Ang, Jacob P. Hoj, Yunqiang Chu, Patrick Tan, Kris C. Wood +2 more

A first-in-class EGFR-directed KRAS G12V selective inhibitor

Cancer Cell(2025)10.1016/j.ccell.2025.05.016

N/A

0DataRank · unranked

23 citations

Hayden P. Huggins, Snehasudha S Sahoo, Alessandro Porrello, Yogitha Chareddy, Salma H. Azam +20 more

Inverted chimeric RNAi molecules synergistically cotarget MYC and KRAS in KRAS-driven cancers

Journal of Clinical Investigation(2025)10.1172/jci187204

N/A

0DataRank · unranked

8 citations

Hayden P. Huggins, Snehasudha S Sahoo, Lyla J. Stanland, Christina Gutierrez-Ford, Kristina M Whately +11 more